Publication | Closed Access

Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)

Durvalumab Consolidation TherapyMedicineMetronomic TherapyReal-world SurveyBronchial NeoplasmDurvalumab ApprovalPulmonary MedicineCancer TreatmentOncologyRadiation OncologyLung CancerCancer Research